ARTICLE | Clinical News
Graspa: Phase IIb started
July 15, 2013 7:00 AM UTC
Erytech said in March it began the open-label, European Phase IIb GRASPA-ML trial to compare 100 IU/kg Graspa in combination with low-dose cytarabine vs. cytarabine alone in about 123 patients ages 65...